Table 3.
Characteristic | Total n (%) (Total = 255) |
Years | p-Value | ||
---|---|---|---|---|---|
2019 n (%) (Total = 114) |
2020 n (%) (Total = 78) |
2021 n (%) (Total = 63) |
|||
Gender | |||||
Male | 157 (61.6) | 66 (57.9) | 52 (66.7) | 39 (61.9) | 0.470 |
Female | 98 (38.4) | 48 (42.1) | 26 (33.3) | 24 (38.1) | |
Age | |||||
Adult (19–44 years) | 54 (21.2) | 33 (28.9) | 11 (14.1) | 10 (15.9) | 0.256 |
Adult (45–64 years) | 72 (28.2) | 29 (25.4) | 24 (30.8) | 19 (30.2) | |
Adult (65–84 years) | 113 (44.3) | 46 (40.4) | 38 (48.7) | 29 (46) | |
Adult (⇒85 years) | 16 (6.3) | 6 (5.3) | 5 (6.4) | 5 (7.9) | |
Source of specimen | |||||
Miscellaneous | 31 (12.2) | 12 (10.5) | 14 (17.9) | 5 (7.9) | 0.003 ** |
Blood | 26 (10.2) | 12 (10.5) | 3 (3.8) | 11 (17.5) | |
Respiratory | 178 (69.8) | 75 (65.8) | 56 (71.8) | 47 (74.6) | |
Urine | 20 (7.8) | 15 (13.2) | 5 (6.4) | 0 (0) | |
Clinical presentation/infection | |||||
Fever | 34 (13.4) | 18 (15.8) | 12 (15.4) | 4 (6.3) | 0.182 |
Sepsis | 25 (9.8) | 9 (7.9) | 7 (9) | 9 (14.3) | 0.375 |
Septic shock | 40 (15.7) | 22 (19.3) | 5 (6.4) | 13 (20.6) | 0.025 * |
Respiratory | 195 (76.5) | 102 (89.5) | 63 (80.8) | 30 (47.6) | <0.001 ** |
GIT | 8 (3.1) | 5 (4.4) | 2 (2.6) | 1 (1.6) | 0.558 |
UTI | 32 (12.5) | 16 (14) | 12 (15.4) | 4 (6.3) | 0.222 |
WI | 46 (18) | 24 (21.1) | 12 (15.4) | 10 (15.9) | 0.529 |
Pneumonia | 117 (45.9) | 27 (23.7) | 38 (48.7) | 52 (82.5) | <0.001 ** |
Underlying disease | |||||
Kidney disease | 90 (35.3) | 42 (36.8) | 28 (35.9) | 20 (31.7) | 0.787 |
Heart disease | 101 (39.6) | 44 (38.6) | 35 (44.9) | 22 (34.9) | 0.465 |
Liver disease | 32 (12.5) | 26 (22.8) | 4 (5.1) | 2 (3.2) | <0.001 ** |
Brain disorder | 68 (26.7) | 34 (29.8) | 24 (30.8) | 10 (15.9) | 0.082 |
Cancer | 33 (12.9) | 23 (20.2) | 4 (5.1) | 6 (9.5) | 0.006 ** |
DM | 136 (53.3) | 56 (49.1) | 44 (56.4) | 36 (57.1) | 0.478 |
Asthma | 8 (3.1) | 4 (3.5) | 2 (2.6) | 2 (3.2) | 0.934 |
HTN | 152 (59.6) | 55 (48.2) | 54 (69.2) | 43 (68.3) | 0.004 ** |
Risk factors | |||||
Mechanical ventilation | 93 (36.5) | 23 (20.2) | 24 (30.8) | 46 (73) | <0.001 ** |
COVID-19 | 37 (14.5) | 0 (0) | 14 (17.9) | 23 (36.5) | <0.001 ** |
Outcome | |||||
Died | 142 (55.7) | 71 (62.3) | 35 (44.9) | 36 (57.1) | 0.002 ** |
Treated | 82 (32.2) | 35 (30.7) | 24 (30.8) | 23 (36.5) | |
Transferred | 31 (12.2) | 8 (7) | 19 (24.4) | 4 (6.3) |
* Statistically significant; the number of * represents the degree of significance. GIT, gastrointestinal tract; UTI, urinary tract infection; WI, wound infection; DM, diabetes mellitus; HTN, hypertension; COVID-19, coronavirus disease 2019.